Riskpilot← Back to searchSign inGet full accessVESTLI APOTEK AS
ASActiveOrg 915049508Vestlisvingen 188, 0969 OsloRetail sale of pharmaceutical products · NACE 4773Est. 20156 employees
Revenue 2024
NOK 17M
+11% vs 2023
EBITDA margin
6.0%
+7% vs 2023
Equity ratio
-46.9%
Financial strength
Net profit 2024
NOK 578K
+18% vs 2023
| Revenue | NOK 17M | +11% |
| EBITDA | NOK 1M | +7% |
| Net profit | NOK 578K | +18% |
| Total assets | NOK 2,8M | -25% |
| Equity | NOK -1,3M | +30% |
| Employees | 6 | — |
Legal name
VESTLI APOTEK AS
Org number
915049508
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2. mars 2015
Share capital
NOK 1 462 419
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Vestlisvingen 188, 0969 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 290 | 14 698 | 17 206 | 15 306 | 17 001 |
| Staff expenses | −1 831 | −3 188 | −2 094 | −1 779 | −1 945 |
| EBITDA | 62 | −1 715 | −2 478 | 955 | 1 020 |
| Depreciation & amort. | −90 | −90 | −94 | −51 | −55 |
| EBIT | −28 | −1 804 | −2 573 | 904 | 965 |
| Net financials | −94 | −138 | −223 | −321 | −229 |
| Profit before tax | −123 | −1 942 | −2 796 | 583 | 737 |
| Tax | −27 | −27 | −0 | 95 | 159 |
| Net profit | −95 | −1 916 | −2 796 | 488 | 578 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 396 | 6 653 | 2 300 | 3 799 | 2 849 |
| Equity | 2 270 | 324 | −2 471 | −1 915 | −1 337 |
| Long-term debt | 3 133 | 3 652 | 3 238 | 2 818 | 1 959 |
| Short-term debt | 1 992 | 2 677 | 1 533 | 2 896 | 2 226 |
| Total debt | 5 125 | 6 329 | 4 771 | 5 714 | 4 185 |
EBITDA margin
6.0%
This company
15.8%
Market median
-62% vs market
20202024
Equity ratio
-46.9%
This company
38.2%
Market median
-223% vs market
20202024
Return on equity
57764300.0%
This company
18.4%
Market median
+313936313% vs market
20202024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20202024
Asset turnover
5.97×
This company
1.12×
Market median
+433% vs market
20202024
Debt / equity
3.13×
This company
0.62×
Market median
-405% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TA Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2023 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 | |
| Company | 51.01% | 51.01% | 2024 | |
| Individual | 24.49% | 24.49% | 2024 | |
| Company | 24.49% | 24.49% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VESTLI APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Andersen | Chief Executive Officer | 0 companies |
| Helge Fauskrud | Board of Directors | 0 companies |
| Hans Mogens Christensen | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Chairman | 0 companies |
| Anders Brekke | Board of Directors | 0 companies |
| Gulzeb Aziz | Board of Directors | 0 companies |